EP-1362: Hypofractionated Simultaneous Integrated Boost IMRT in high risk prostate cancer – A novel approach. (April 2016) - Sashidharan, S.; Beena, K.; Chelakkot G, P.; Madhavan, R.; Menon, D.; Makuny, D.